News Releases

Moffitt Researchers Develop Synthesis Method to Enhance Access to Cancer-Fighting Withanolides

Scalable production of the bioactive compound will advance cancer research and treatment development

Revolutionizing Ovarian Cancer Treatment With Adaptive PARP Inhibitor Therapy

Innovative Study Reveals Dose Modulation as Key to Reducing Toxicity and Combating Resistance

Moffitt Cancer Center Achieves Prestigious Nursing Magnet Recognition

This is the third time Moffitt has earned the designation

Moffitt Study Reveals New Mechanism of Drug Resistance in Melanoma Leptomeningeal Disease

Findings uncover key tumor-stroma interactions and a potential therapeutic target

Moffitt Earns 2024 LGBTQ+ Healthcare Equality Leader Designation

The cancer center is one of 384 health care facilities nationwide to earn the title and the only one in the Tampa Bay area

Engineering Cancer’s End: Moffitt Scientists Say Bioengineering Will Change Our Ability to Research and Treat Cancer

Commentary in Cancer Cell discusses why this area of science is the future

Innovative Combination Therapy Shows Promise for Bladder Cancer Patients Unresponsive to Standard Treatment

CORE-001 trial demonstrates efficacy of oncolytic virus and immune checkpoint inhibitor in treating non-muscle invasive bladder cancer

Moffitt Cancer Center and Virogen Biotechnology Forge Groundbreaking Partnership to Accelerate Oncology and Immunotherapy Innovations

Collaboration to expedite development of revolutionary fusion protein VG712 enhances treatment options for cancer patients and advances immunotherapy...

Moffitt Cancer Center Uses AI to Develop More Personalized Cancer Treatment Strategies

Innovative study harnesses deep reinforcement learning to tailor adaptive treatment schedules for metastatic prostate cancer, doubling time to...

Joanna Weiss Appointed Moffitt’s Chief Financial Officer

She will oversee all financial operations for the cancer center

Moffitt Cancer Center and Fulgent Pharma Join Forces To Revolutionize Cancer Therapeutics

Collaboration aims to accelerate the development of personalized therapies and transform patient care through the use of precision medicine

Oncology Nursing Certification Corporation Employer Recognition Award Goes to Moffitt

This is the cancer center’s second time being recognized

Moffitt Initiates Groundbreaking Clinical Trial with Oncolytic Virus for Non-Small Cell Lung Cancer

The phase 1 trial is evaluating MEM-288 in combination with nivolumab

Moffitt Study Suggests Cells Possess Hidden Communication System

New research finds ion gradients across membranes form an information network for rapid cellular decision-making independent of DNA

Moffitt Researchers Discover New Therapeutic Target for Non-Small Cell Lung Cancer

Disrupting Jagged2 signaling reprograms immune cells to fight tumors